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Background: While non-rigid fusion is by definition expected to alter the information of positron emission
tomography (PET) data, we assessed whether rigid transformation also influences metabolic tumor volume (MTV)
determination.
Methods: The PET/computed tomography (CT) data of 28 solid pulmonary lesions of 20 tumor patients examined
with 18 F-Fluordeoxyglucose (FDG) was retrospectively analyzed. The original (OR) hardware-coregistered PET images
were fused with contrast-enhanced diagnostic CT (CT1, 1 mm slices) and low dose CT (CT5, 5 mm slices). After
automatic rigid transformation (Mirada Fusion7D) using two algorithms (rigid fast (RF), rigid slow (RS)), MTV and
maximal standardized uptake value (SUVmax) were determined applying four different segmentation methods with
either fixed or background-adapted thresholding and compared to OR-PET data.
Results: Relative differences in SUVmax compared to OR data revealed no significant differences for RF
(median, −0.1%; interquartile range (IQR), −1.1% to 0.9%; p = 0.75) and RS (median, 0.5%; IQR, −0.6% to 1.3%;
p = 0.19) in CT1, whereas in CT5 significant deviations were observed for RF (median, −9.0%; IQR, −10.9 to −6.1;
p < 0.001) and RS (median, −8.4%; IQR, −11.1 to −5.6; p < 0.001). Relative MTV differences were 0.7% (IQR, −3.0% to
2.7%; p = 0.76) for RF and −1.3% (IQR, −3.6% to 0.9%; p = 0.12) for RS in CT1. Coregistration led to significant MTV
differences in RF (median, 10.4%; IQR, 7.4% to 16.7%; p < 0.001) and RS (median, 10.6%; IQR, 5.4% to 17.7%;
p < 0.001) in CT5.
Conclusions: Rigid coregistration of PET data allows a quantitative evaluation with reasonable accuracy in most
cases. However, in some cases, it can result in substantial deviations of MTV and SUVmax. Therefore, it is
recommended to perform quantitative evaluation in the original PET data rather than in coregistered PET data.
Keywords: Coregistration; Interpolation; PET; CT; Metabolic tumor volume; SUVBackground
Image fusion, initially software-based, is an established
procedure in nuclear medicine (NM) [1,2], and both
rigid and non-rigid coregistration approaches still are
the research focus of many groups [3,4]. While modern
hybrid-tomographs usually provide an appropriate align-
ment of functional positron emission tomography (PET)
and morphological computed tomography (CT), changes
in breathing pattern between both examinations or* Correspondence: ingo.steffen@med.ovgu.de
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in any medium, provided the original work is pphysiological organ and/or patient movement may lead
from slight to grave incongruences of the two 3D-data
sets to be matched [5-8]. Thus, automatic or manual
software-based fine-tuning is commonplace in order to
create a better match of the relevant anato-metabolic
findings [9].
In PET imaging, it is commonplace to assess tumor
metabolism not only qualitatively (i.e., visual analysis)
but also quantitatively. Apart from the established stan-
dardized uptake value (SUV) determination, more re-
cently tumor volume measurements have been reported
that could be of value especially in therapy assessment
[10] and radiation oncology [11-13]. In addition to in-
trinsic hardware-based image fusion supplied by PET/
CT-hybrid-devices, software-based fine-tuning is possiblean open access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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example, for the planning of radiation therapy [11].
While elastic (non-rigid, deformable) fusion is ex-
pected to alter the information of PET data, the present
study assessed whether the corresponding interpola-
tion also has an impact on semiquantification in a




The PET/CT data of 20 lung cancer patients (12 male, 8
female; median age, 71.3 years; range, 57 to 82 years)
with a total of 28 solid lung lesions were included. This
retrospective study was approved by the local ethics
committee (application no. EA2/143/12), and all patients
signed a written informed consent.
PET/CT data acquisition
Patients received a whole-body PET/CT examination
with 18 F-Fluordeoxyglucose (FDG) (Biograph 16, Siemens
Medical, Erlangen, Germany). The PET protocol included
an 8-h fasting period followed by confirmation of a blood
glucose level ≤ 110 mg/dl prior to the scanning procedure.
PET scans were performed 90 min after intravenous injec-
tion of 250 to 380 MBq (median, 300 MBq) FDG (five to
six bed positions at 3 min each; matrix size, 168 × 168;
voxel size, 4.1 × 4.1 × 5.0 mm).
CT imaging first consisted of an unenhanced low-dose
CT (40 mAs/120 kV; detector collimation, 16 × 1.5 mm)
reconstructed with a slice thickness of 5 mm (matrix
size, 512 × 512; voxel size, 1.4 × 1.4 × 5.0 mm). From this
scan also, the attenuation map necessary for the attenu-
ation correction of PET data was derived. Subsequently,
a dedicated CT scan using CareDose4D® (part of Somatom
16 Software, Version B10, Siemens Medical, Erlangen,
Germany) automatic dose regulation technology (230
mAs/120 kV; detector collimation, 16 × 1.5 mm) was per-
formed using intravenous contrast enhancement (70 to
100 ml Ultravist 370, Bayer Schering Pharma, Berlin,
Germany/venous phase with 70 s delay) and a recon-
structed slice thickness of 1 mm (matrix size, 512 × 512,
voxel size, 1.4 × 1.4 × 1.0 mm).
For all scans, the patients were in the supine position
with arms elevated and they were instructed to retain a
shallow breathing pattern throughout the low-dose CT
scan and the PET acquisition in order to minimize
motion-induced attenuation correction artifacts. The
diagnostic CT scan was acquired during the inspiration
phase. PET images were reconstructed using an iterative
two-dimensional ordered subset expectation maximiza-
tion algorithm (2D OSEM, 4 iterations, 8 subsets, 5 mm
FWHM Gaussian filter) including correction for scatter
and attenuation.Image registration
Coregistration was performed using Mirada Fusion 7D
(Build FUSM 1.0.0.8, Broker 5.5.6.7, Mirada Solutions,
Oxford, UK) on a Leonardo workstation (CPU, Intel
Xeon 3,2 GHz; OS, Windows XP Prof., SP3; RAM, 3GB;
e.soft Software, Version 4.0, Siemens Medical Solutions,
Erlangen, Germany). Only thoracic slices (lung apices
to diaphragm) were selected for coregistration. Digital
imaging and communications in medicine (DICOM)
images were transferred from the workstation to the
Mirada software using the Mirada DICOM broker
selecting CT images as source data and corresponding
PET images as target data. Rigid coregistration was per-
formed using the ‘rigid fast’ (RF) and the ‘rigid slow’
(RS) mode available in the Mirada software. Both algo-
rithms are based on mutual information with the main
difference being the number of samples used for the
similarity function (for example, the slow algorithm is
supposed to be more accurate but is more time-
consuming). Original PET data as well as coregistered
PET data were saved in the CT geometry and pixel size
for CT1 and CT5, respectively. In the following, we refer
to the resampled original data (hardware coregistered) as
original (OR) data.
The median coregistration times for CT5 were 7.4 s
(interquartile range (IQR), 6.7 to 7.9 s) using RF and
101.2 s (IQR, 92.5 to 119.3 s) applying RS with a corre-
sponding median ratio of 15.6 (IQR, 13.1 to 16.5). In
CT1, the median coregistration times were 9.1 s (IQR,
8.3 to 10.2 s) for RF and 80.6 s (IQR, 73.2 to 92.5 s) for
RS with a corresponding median ratio of 8.6 (IQR,
8.0 to 10.1).
Metabolic volumetry
Lesions in PET were delineated using dedicated software
(Rover, Version 2.1.8, ABX GmbH, Radeberg, Germany)
applying four different segmentation methods. First, an
adaptive threshold method (AT), which applies a
volume-reproducing threshold after subtraction of local
background, was used [14]. The other segmentation me-
thods are based on fixed thresholds delineating all voxels
with an activity concentration of at least 40% (T40),
50% (T50), or 60% (T60) of the measured maximum
activity, respectively. In all lesions, SUVmax, meta-
bolic tumor volume (MTV) and total lesion glycolysis
(TLG, MTV*SUVmean) were determined for OR and
for the coregistered (RS/RF) PET data, using both CT1
and CT5.
Statistical methods
All calculations were performed using the R-system for
statistical computing (version 2.15.3, R Foundation for
statistical Computing, Vienna, Austria, http://www.R-
project.org). Descriptive parameters were expressed as
Steffen et al. EJNMMI Research 2013, 3:85 Page 3 of 9
http://www.ejnmmires.com/content/3/1/85mean, median, IQR, and range. Differences between ori-
ginal and coregistered date were analyzed using non-
parametric Wilcoxon test for paired data. Agreement of
different methods was analyzed using Bland-Altman
plots [15] and 95% limits of agreement (95% LoA). All
tests were two-sided, and statistical significance was as-
sumed at p < 0.05.Results and discussion
Results
Original PET data
The MTV of original PET data was 3.2 (IQR, 2.4 to 6.2)
ml and ranged from 1.1 to 27.2 ml with a median SUV-
max of 9.0 (5.6 to 12.8) ranging from 1.6 to 30.9. The
TLG of original PET data showed a median of 13.9 (8.7
to 51.7) ml and ranged from 3.4 to 370.1 ml. After the
resampling step leading to OR data, the SUVmax
remained essentially unchanged (median, 8.8; IQR, 5.8
to 12.6; range, 1.6 to 30.3).SUVmax differences between OR and coregistered PET data
CT1. Median SUVmax in OR was 8.8 (5.6 to 12.6) and
showed no significant differences compared to median
SUVmax of 8.7 (5.6 to 12.5) in RF (p = 0.75) and 8.7 (5.6
to 12.5) in RS (p = 0.19). The median relative SUVmax
differences were −0.1 (−1.1% to 0.9%) ranging bet-
ween −2.3% and 2.8% in RF and 0.5 (−0.6% to 1.3%)
ranging between −2.3% and 2.5% in RS.
CT5. Median SUVmax decreased significantly from 8.8
(5.6 to 12.6) in OR to 8.1 (5.2 to 11.7) in RF (p < 0.001)
and to 8.0 (5.4 to 11.5) in RS (p < 0.001) with median
relative SUVmax differences of −9.0 (−10.9% to −6.1%)
ranging from −18.2% to −1.1% in RF and with median
relative SUVmax differences of −8.4 (−11.1% to −5.6%)
ranging from −19.4% to 4.3% in RS.MTV differences between OR and coregistered PET data
CT1. Median MTV in OR was 3.3 (2.4 to 5.9) ml and
showed no significant differences compared to median
MTV of 3.1 (2.3 to 5.9) ml in RF (p = 0.76) and 3.1 (2.3
to 5.8) ml in RS (p = 0.12). Relative MTV differences
ranged from −12.7% to 9.2% (median, 0.7%; IQR, −3.0% to
2.7%) for RF and from −16.1% to 14.1% (median, −1.3%;
IQR, −3.6% to 0.9%) for RS.
CT5. While the median MTV in OR measured 3.3 ml
(IQR, 2.4 ml to 6.0 ml), it increased significantly to
3.6 ml (IQR, 2.7 to 6.4 ml) in RF (p < 0.001) and to
3.5 ml (IQR, 2.7 to 6.5 ml) in RS (p < 0.001). Accor-
dingly, relative MTV differences showed a median of
10.4% (IQR, 7.4% to 16.7%; range, −11.7% to 48.0%) in
RF and 10.6% (IQR, 5.4% to 17.7%; range, −17.0% to
42.7%) in RS.TLG differences between OR and coregistered PET data
CT1. OR data featured a median TLG of 12.5 (8.1 to 48.4)
ml with no significant differences compared to 12.7 (8.4 to
47.8) ml in RF (p = 0.40) and 12.5 (8.1 to 47.5) ml in RS
(p = 0.12). The corresponding median relative TLG differ-
ences were 0.5 (−2.2% to 1.9%) ranging from −9.9% to
6.5% in RF and −0.9 (−2.4% to 0.6%) ranging from −12.6%
to 10.2% in RS.
CT5. The median TLG in OR was 13.6 (8.5 to 50.5) ml
and increased significantly to 13.7 (9.8 to 51.0) ml in RF
(p < 0.05). In contrast, no significant difference was ob-
served after coregistration with RS with a median of 14.4
(9.2 to 51.1) ml (p = 0.13). The median relative TLG dif-
ferences measured 2.0 (−0.5% to 4.8%) ranging bet-
ween −12.2% and 22.1% in RF and 1.6 (−2.1% to 5.8%)
ranging between −15.7% and 20.8% in RS.
Association of MTV and segmentation methods
CT1. Relative MTV differences for RF based on dif-
ferent segmentation algorithms showed a median of
0.7 (IQR, −3.0% to 2.7%) (AT), 0.2 (−1.2% to 1.8%)
(T40), 0.3 (−1.8% to 2.7%) (T50), and 0.7 (−2.6% to
4.0%) (T60), respectively. The corresponding results
for RS were −1.3 (−3.6% to 0.9%) (AT), −1.0 (−2.8%
to 1.2%) (T40), −1.0 (−2.5% to 1.4%) (T50), and −1.3
(−4.0% to 1.2%) (T60). For RF as well as RS data, the
Wilcoxon test revealed significant differences neither
between AT and T40 (RF, p = 0.69; RS, p = 0.35), nor be-
tween ATand T50 (RF, p = 0.49; RS, p = 0.35), and nor be-
tween AT and T60 (RF, p = 0.49; RS, p = 0.70).
CT5. Median relative MTV differences for RF mea-
sured 10.5 (7.4% to 16.7%) (AT), 12.9 (9.1% to 21.2%)
(T40), 11.7 (7.8% to 17.2%) (T50), and 9.4 (4.8% to
15.4%) (T60), respectively. Relative MTV differences for
RS showed a median of 10.6 (5.4% to 17.7%) (AT), 12.6
(8.1% to 23.4%) (T40), 13.1 (7.4% to 18.6%) (T50), and
9.9 (3.4% to 17.8%) (T60). For RF as well as RS data, the
Wilcoxon test revealed significant differences between
AT and T40 (both p < 0.05) but not between AT and T50
(RF, p = 0.20; RS, p = 0.12) or AT and T60 (RF, p = 0.69;
RS, p = 0.45), respectively.
Descriptive parameters of unsigned absolute and rela-
tive differences between OR and coregistered PET data
are given in Tables 1, 2, and 3. Corresponding relative dif-
ferences are depicted as Bland-Altman plots in Figure 1.
The unsigned relative differences are displayed as boxplots
in Figure 2. Relative MTV differences between OR and
coregistered PET data for different segmentation algo-
rithms are presented in Table 4 and depicted as Bland-
Altman plots in Figure 3. An example demonstrating the
differences of MTV and SUVmax between OR and core-
gistered PET data is given in Figure 4. Figure 5 illustrates
the influence of tracer distribution on interpolation ef-
fects, e.g., due to tumor heterogeneity.
Table 3 Unsigned differences in TLG after coregistration
RF RS
ΔTLG (ml) ΔTLG (%) ΔTLG (ml) ΔTLG (%)
CT1
Mean 0.9 2.9 0.6 3.2
Median 0.4 2.1 0.4 1.8
IQR 0.2 to 0.7 1.2 to 4.2 0.2 to 0.8 0.8 to 4.8
Range 0.0 to 8.1 0.2 to 9.9 0.1 to 2.2 0.2 to 12.6
CT5
Mean 2.1 5.3 2.1 5.4
Median 0.6 3.2 0.7 3.8
IQR 0.2 to 1.8 1.7 to 5.3 0.5 to 0.9 1.9 to 6.1
Range 0.0 to 20.6 0.1 to 22.1 0.0 to 20.3 0.3 to 20.8
RF, rigid fast; RS, rigid slow; CT1, 1-mm-slice thickness; CT5, 5-mm-slice
thickness.
Table 1 Unsigned differences in SUVmax after
coregistration
RF RS
ΔSUVmax ΔSUVmax (%) ΔSUVmax ΔSUVmax (%)
CT1
Mean 0.1 1.1 0.1 1.0
Median 0.1 1.0 0.1 0.8
IQR 0 to 0.2 0.4 to 1.6 0.0 to 0.1 0.5 to 1.5
Range 0.0 to 0.7 0.1 to 2.8 0.0 to 0.5 0.0 to 2.5
CT5
Mean 0.9 9.0 1.0 8.8
Median 0.7 9.0 0.8 8.4
IQR 0.5 to 1.3 6.1 to 10.9 0.3 to 1.3 5.6 to 11.1
Range 0.0 to 2.9 1.1 to 18.2 0.0 to 3.0 1.6 to 19.4
RF, rigid fast; RS, rigid slow; CT1, 1-mm-slice thickness; CT5, 5-mm-slice
thickness.
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Recent uses of PET data for staging, therapy assessment,
and definition of target volume for irradiation indicate
that the sole definition of the traditional SUVmax, based
on a single voxel, may be insufficient. As a consequence,
the assessment of the whole metabolic tumor volume or
the determination of total lesion glycolysis [16] has been
suggested. However, the accurate delineation of a PET
positive lesion is difficult as manual segmentation is as-
sociated with a large intra- and interobserver variability
and fixed thresholds have been proven to be inadequate
[17]. To overcome this problem, several automatic delin-
eation methods have been proposed [18-23], but up to
the present, no general consensus about the best method
exists. In this study, we used a method which applies a
volume-reproducing intensity threshold after subtractionTable 2 Unsigned differences in metabolic tumor
volumes (MTV) after coregistration
RF RS
ΔMTV (ml) ΔMTV (%) ΔMTV (ml) ΔMTV (%)
CT1
Mean 0.2 4.0 0.2 4.4
Median 0.1 2.9 0.1 2.7
IQR 0.1 to 0.2 1.8 to 5.8 0.1 to 0.2 1.2 to 6.4
Range 0.0 to 1.4 0.2 to 12.7 0.0 to 0.9 0.0 to 16.1
CT5
Mean 0.6 14.4 0.6 13.7
Median 0.4 11.4 0.4 10.7
IQR 0.3 to 0.5 7.6 to 16.7 0.2 to 0.6 6.8 to 17.7
Range 0.0 to 4.3 0.1 to 48.0 0.0 to 4.5 0.8 to 42.7
RF, rigid fast; RS, rigid slow; CT1, 1-mm-slice thickness; CT5, 5-mm-slice
thickness.of local background. The method seems promising [14]
and is implemented in commercial software available at
our site. Since fixed thresholds are still frequently used
[24,25], we also investigated three different thresholds
(see the following paragraphs).
It has already been shown that quantification of PET
is affected by a multitude of biological and technical fac-
tors influencing PET acquisition and reconstruction
[26,27]. The effect of different reconstruction algorithms
on PET-based volume segmentation was analyzed in a
recent study and showed a substantial influence of re-
construction algorithms on segmentation thresholds [28].
In the present study, the images were reconstructed as
usually performed in our clinical routine (2D-OSEM), and
the effect of rigid coregistration on PET quantification
was observed. The applied two mutual information-based
rigid coregistration algorithms (RF and RS) allow user-
independent translations and rotations of the PET data.
Both algorithms showed deviations of SUVmax and meta-
bolic tumor volume compared to original coregistration
algorithm in a similar range.
However, it has to be emphasized that the focus of the
recent study was not to determine the accuracy of the
different coregistration algorithms as no reference stand-
ard was available for this issue. It is obvious that the
final result of the OR data may be influenced by motion
blur or incongruence of PET and CT data due to diffe-
rent organ positions (not to mention the attenuation
correction errors associated therewith) [29]. However,
the aim was to demonstrate in a proof of principle that
notable deviations can be observed also after mere rigid
transformations using coregistration algorithms as usu-
ally performed in clinical routine.
On average, the observed deviations of SUVmax,
MTV, and TLG are rather small (see Tables 1, 2, and 3).
For the PET data coregistered to CT1 also, the maximum
Figure 1 Bland-Altman plots of relative changes in SUVmax, MTV, and TLG. Relative changes after coregistration to CT1 and CT5 using the
RF and RS coregistration algorithm of 28 lesions in 20 patients. Differences are calculated as coregistered data - original data. Solid and dashed
lines represent mean ± 2SD.
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TLG, 12.6%) while the PET data coregistered to the
coarsely sliced CT5 showed strong deviations in some
cases (maximum differences, SUVmax, 19.4%; MTV,
48.0%; TLG, 22.1%). This is an expected result, since
in general on a coarse grid, interpolation effects are
more pronounced than on a fine grid independent of
the interpolation method. CT5 had a slice thickness
of 5 mm compared to 1 mm of CT1. The in-plane
voxel size was the same for both CTs. It can be ex-
pected that for larger in-plane voxel sizes (e.g., core-
gistration of two follow up PETs), deviations are even
larger and occur more often.
Besides the target voxel grid, the interpolation method
directly influences the deviation of SUVmax, MTV, andFigure 2 Box plots of relative changes in SUVmax, MTV, and TLG. Rela
algorithm of 28 lesions in 20 patients (unsigned). Outliers are marked by ciTLG. The interpolation method implemented in the used
coregistration software is trilinear interpolation. There-
fore, our results are strictly speaking only valid for the ap-
plied coregistration software. However, similar effects can
be expected with other coregistration software.
The transformation parameters used for coregistration
also have direct influence on the interpolation effects. If,
for example, the data are shifted by a multiple of the
voxel size, the data are not interpolated at all. On the
other hand, if the data are shifted by half of the voxel
size (plus an arbitrary multiple of the voxel size), the
interpolation effects are maximal. This effect can also be
observed in our results: all large deviations in SUVmax,
MTV, and TLG were associated with shifts clearly devi-
ating from multiples of the voxel size while in mosttive changes for CT5 and CT1 using the RF and RS coregistration
rcles.
Table 4 Relative differences in MTV for different
segmentation algorithms (AT, T40, T50, T60) after
coregistration
AT T40 T50 T60
CT1 (RF)
Mean −0.5 0.1 0.2 0.5
Median 0.7 0.2 0.3 0.7
IQR −3.0 to 2.7 −1.2 to 1.8 −1.8 to 2.7 −2.6 to 4.0
Range −12.7 to 9.2 −4.7 to 4.7 −5.8 to 4.3 −7.9 to 8.1
CT5 (RF)
Mean 13.6 16.9 15.1 13.2
Median 10.5 12.9 11.7 9.4
IQR 7.4 to 16.7 9.1 to 21.2 7.8 to 17.2 4.8 to 15.4
Range −11.7 to 48.0 −1.9 to 51.6 −7.1 to 73.1 −10.0 to 64.5
CT1 (RS)
Mean −1.0 −0.9 −0.8 −1.1
Median −1.3 −1.0 −1.0 −1.3
IQR −3.6 to 0.9 −2.8 to 1.2 −2.5 to 1.4 −4.0 to 1.2
Range −16.1 to 14.1 −5.5 to 4.1 −5.6 to 5.3 −8.0 to 6.9
CT5 (RS)
Mean 12.5 14.7 13.6 13.0
Median 10.6 12.6 13.1 9.9
IQR 5.4 to 17.7 8.1 to 23.4 7.4 to 18.6 3.4 to 17.8
Range −17.0 to 42.7 −9.5 to 44.0 −13.2 to 57.4 −5.8 to 66.8
RF, rigid fast; RS, rigid slow; CT1, 1-mm-slice thickness; CT5, 5-mm-slice
thickness.
Figure 3 Bland-Altman plots of relative changes in MTV for different
segmentation algorithms after coregistration to CT1 and CT5 using the RF
are calculated as coregistered data - original data. Solid and dashed lines re
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voxel size. In general, the transformation parameters, ne-
cessary for an optimal coregistration, are not predictable
and, thus, also the magnitude of the interpolation effects
is not predictable.
Finally, the immediate neighborhood of the maximum
voxel determines the magnitude of the potential inter-
polation effect. For a large homogeneous lesion, the dif-
ference of maximum voxel and neighboring voxel is just
noise and the interpolation effects essentially lead to
noise reduction (assuming trilinear interpolation). This
is different for small or heterogeneous lesions. For small
lesions (compared to the spatial resolution), the neigh-
borhood of the maximum voxel is usually lowered by
partial volume effects, and therefore, interpolation ef-
fects are increased. It should be noted that for very small
lesions, the maximum voxel itself is compromised by
limited signal recovery already in the original image and
should be interpreted with care even without interpola-
tion effects.
However, also larger but heterogeneous lesions can
have substantial interpolation effects as can be seen in
Figure 5, where two lesions with approximately the same
volume but different heterogeneity are shown. For the
heterogeneous lesion (Figure 5A), the SUVmax is de-
creased by 18%, MTV is increased by 39%, and TLG by
20% (all for CT5 and RF) which might be a notable
impact, for example, on the repeated measurement in
follow-up studies due to error propagation or in the field
of PET-based planning of radiotherapy [30,31] where
an accurate MTV definition is important. On the other
hand, for the rather homogeneous lesion shown in
Figure 5B, the deviation of SUVmax and MTV issegmentation algorithms. Relative MTV changes for different
and RS coregistration algorithm in 28 lesions in 20 patients. Differences
present mean ± 2SD.
Figure 4 Coronal visualization of a pulmonary PET positive lesion coregistered to CT1 and CT5. The anatomical localization is indicated by
the red square. The detailed view of this region shows the respective delineation (yellow line) of the voxels included in the MTV-calculation of
the original scan (OR) and after transformation (RF, RS).
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table in most cases.
MTV was determined with an adaptive threshold
method, which is routinely used at our site. Additionally,
the lesions were delineated applying three different fixed
thresholds. For all delineation methods, the deviation of
MTV was comparable, where the adaptive threshold
method resulted in slightly lower deviations for CT5 and
the fixed threshold method showed slightly lower devia-
tions for CT1 (see Figure 3). It should be noted that the
present study assessed only the deviation of MTV after
coregistration but not the delineation accuracy.
A recent study analyzed the effect of rigid and non-
rigid coregistration methods on SUVmax and MTV in
association with different breathing maneuvers in pa-
tients with lung cancer [4]. Whereas MTV was signifi-
cantly influenced by the choice of registration method
depending on breathing protocol, no significant impact
on SUVmax was observed. As the present study analyses
the difference between coregistered and original data, a
comparison of both studies is difficult. However, the re-
ported range of mean relative SUVmax changes (−18%
to 20%) and MTV changes (−43% to 61%) correspondsFigure 5 Coronal visualization of two pulmonary PET positive lesions
different heterogeneity. The first lesion (A) has a central necrosis, leading to
after coregistration. For the second, rather homogeneous lesion (B), the difto the current study. A further study investigated the
effect of rigid and non-rigid image registration on test-
retest (TRT) variability of SUV and MTV in patients
with colorectal carcinoma [3]. Significant differences in
TRT compared to the reference were only observed for
the MTV after rigid registration but neither for MTV
after non-rigid registration nor for SUVmax. As this
study is based on two different scans for each patient,
the design differs substantially from the current ap-
proach. However, median TRT variability was about 10%
for SUVmax and 15% for MTV in the reference group
with corresponding maximums of about 25% for SUV-
max and 50% for MTV which is in the range of the
present study.
A limitation of our study is that only threshold-based
delineation methods were used for MTV determination.
It cannot be excluded that the observed deviations of
MTV are partly caused by using only such methods.
Other delineation algorithms which are not based on
thresholding [21-23] might be less sensitive to inter-
polation effects. However, since these algorithms are not
available at our institution, the observed effects repre-
sent our clinical routine.. The lung lesion exhibiting approximately the same MTV but have
relatively high differences (SUVmax, 17.9%; MTV, 39.2%; TLG, 19.6%)
ferences are substantially lower (SUVmax, 7.4%; MTV, 7.6%; TLG, 1.4%).
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The interpolation due to rigid coregistration of PET and
CT data still allows a quantitative evaluation of PET data
with a reasonable accuracy in most cases. However, in
some cases, it can result in substantial deviations of
MTV and SUVmax. The magnitude of the deviation de-
pends on several factors and is in general not predictable.
Therefore, it is recommended to perform quantitative
evaluation in the original PET data rather than in coregis-
tered PET data.
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